Ticker

Analyst Price Targets — CPSH

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
November 13, 2025 9:30 amRoth Capital$6.00$3.30TheFly CPS Technologies initiated with a Buy at Roth Capital

Latest News for CPSH

CPS Announces Renewal And Capacity Increase Of Credit Facility

LAS VEGAS, July 09, 2026 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that on July 9, 2026, it renewed its two-year revolving credit agreement with Citibank, N.A. while simultaneously increasing the capacity of the facility. The renewal and increase apply to both Citibank, N.A. and the subordinate lender, and increases the capacity of the facility from…

GlobeNewsWire • Jul 9, 2026
Rush Gold Provides Update Regarding Private Placement, Announces Advisory Agreement and Announces Proposed Acquisition of Landy Investments

VANCOUVER, BC – TheNewswire - June 30, 2026 – Rush Gold Corp. (“Rush” or the “Company”) (CSE: RGN | OTCQB: RGNCF | FSE: B6H) is pleased to announce, further to its news releases dated March 11, 2026 and April 17, 2026, that it remains focused on completing its previously announced private placement of common shares (“ Shares ”) at a price of $0.10 per Share (the “ Private Placement ”). The Company is also pleased to…

TheNewswire • Jun 30, 2026
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each in combination with Trodelvy® (sacituzumab govitecan-hziy), Gilead's Trop-2-directed antibody-drug conjugate (ADC), for the…

Business Wire • Jun 25, 2026
CPS Technologies Corp. Announces Pricing of $9.6 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

NORTON, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- CPS Technologies Corp. (NASDAQ: CPSH) (“CPS” or the “Company”), today announced that it has entered into definitive securities purchase agreements with certain institutional investors for the purchase and sale of an aggregate of 1,200,000 shares of the Company's common stock at a purchase price of $8.00 per share in a registered direct offering priced at-the-market…

GlobeNewsWire • May 28, 2026
OCI Energy and CPS Energy break ground on Alamo City Battery Energy Storage Project

One of the largest standalone energy storage projects in the region, Alamo City BESS will bring flexible power and long ‑ term energy resilience to the San Antonio area SAN ANTONIO, May 19, 2026 /PRNewswire/ -- Today, OCI Energy, CPS Energy, and their project teams gathered in southeastern Bexar County to mark the official start of construction on the Alamo City Battery Energy Storage System (BESS). The ceremonial…

PRNewsWire • May 19, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CPSH.

No House trades found for CPSH.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top